← European Medicine Shortage Tracker · all medicines

Sumatriptan succinate shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Sumatriptan succinate currently has availability issues reported in 6 European registers: Austria, Germany, Spain, Ireland, Italy, Sweden.

Shortage  ATC N02CC01 · also listed as: SUMATRIPTAN SUCCINAT · Sumatriptansuccinat · SUMATRIPTAN · Sumatriptan succinate · data refreshed 9 September 2026

Key facts

As of 9 September 2026, 6 of the 9 tracked registers list current availability issues for Sumatriptan succinate, covering 13 affected product presentations. The longest-running open report was filed in Italy on 2024-11-30 and has now been open for about 22 months. Where agencies state a cause, manufacturing problems lead with 5 of the 8 stated-cause reports, followed by commercial decisions or discontinuation with 2. The furthest expected-resolution date currently on file is 2027-05-06; the earliest is 2026-10-10. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 7 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2024-11-30), with Austria following roughly 20 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Sumatriptan succinate is coded N02CC01 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaLimited availability
Sumatriptan 1A Pharma 50 mg - Tabletten
2026-07-31register ↗
🇩🇪 GermanyShortage
Sumatriptan Aurobindo 100 mg Tabletten
2026-07-062026-10-30Probleme in der Herstellung
Alternatives: Sumatriptan Aurobindo 100 mg Tabletten - Einreichungsnummer: 2168271
register ↗
🇪🇸 SpainShortage
SUMATRIPTAN VIATRIS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos
2026-07-292027-05-06Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇮🇪 IrelandShortage
SUMATRAN 50 mg tablets
+ 2 more products
Sumatriptan 100 mg film-coated tablets
Sumatriptan 50 mg film-coated tablets
2026-02-032026-10-30Unexpected increased demand (Multiple countries)
Alternatives: Alternative(s) available — see the national register.
register ↗
🇮🇹 ItalyShortage
SUMATRIPTAN DOC
+ 3 more products
SUMATRIPTAN DOC GENERICI
SUMATRIPTAN ZENTIVA
SUMATRIPTAN ZENTIVA
2024-11-30Cessata commercializzazione temporanea
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗
🇸🇪 SwedenShortage
Sumatriptan Advanz Pharma 12 mg/ml Injektionsvätska, lösning i förf. injektionsp
+ 2 more products
Sumatriptan Teva 50 mg Filmdragerad tablett
Sumatriptan Viatris 50 mg Filmdragerad tablett
2026-05-132026-12-30
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2024-11: 12024-12: 02025-01: 02025-02: 12025-03: 02025-04: 02025-05: 02025-06: 02025-07: 02025-08: 02025-09: 02025-10: 02025-11: 02025-12: 02026-01: 02026-02: 22026-03: 02026-04: 12026-05: 12026-06: 02026-07: 52026-08: 02026-09: 22024-112026-09

Full report history (13 register entries)

Every individual register entry for Sumatriptan succinate in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇸🇪 SESumatriptan Viatris 50 mg Filmdragerad tablettExpected shortage2026-09-302026-12-30
🇸🇪 SESumatriptan Teva 50 mg Filmdragerad tablettExpected shortage2026-09-102026-10-10
🇦🇹 ATSumatriptan 1A Pharma 50 mg - TablettenLimited availability2026-07-31
🇮🇹 ITSUMATRIPTAN DOC GENERICIShortage2026-07-31Problemi produttivi
🇪🇸 ESSUMATRIPTAN VIATRIS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 Shortage2026-07-292027-05-06Existen otros medicamentos con el mismo principio activo y m
🇮🇪 IESUMATRAN 50 mg tabletsShortage2026-07-132026-10-30Unexpected increased demand (Multiple countries)
🇩🇪 DESumatriptan Aurobindo 100 mg TablettenShortage2026-07-062026-10-30Probleme in der Herstellung
🇸🇪 SESumatriptan Advanz Pharma 12 mg/ml Injektionsvätska, lösning i förf. iShortage2026-05-132026-07-28
🇮🇹 ITSUMATRIPTAN DOCShortage2026-04-24Cessata commercializzazione temporanea
🇮🇪 IESumatriptan 100 mg film-coated tabletsShortage2026-02-03Manufacturing delay
🇮🇪 IESumatriptan 50 mg film-coated tabletsShortage2026-02-03Manufacturing delay
🇮🇹 ITSUMATRIPTAN ZENTIVAShortage2025-02-28Motivi commerciali
🇮🇹 ITSUMATRIPTAN ZENTIVAShortage2024-11-30Problemi produttivi

Frequently asked

Is Sumatriptan succinate currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Austria, Germany, Spain, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Sumatriptan succinate shortage expected to end?

Agency prognoses on file range from 2026-10-10 to 2027-05-06. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Sumatriptan succinate?

12 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Sumatriptan succinate availability data come from?

Directly from the official medicines-agency registers that list Sumatriptan succinate: BASG (Austria), BfArM (Germany), AEMPS CIMA (Spain), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Sumatriptan succinate — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/sumatriptan-succinate/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Sumatriptan succinate availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/sumatriptan-succinate/">Sumatriptan succinate shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Sumatriptan succinate: availability status across 6 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.